High Point Opioid Treatment Program (OTP) in Plymouth, MA
The High Point Treatment Center in Plymouth, Massachusetts, offers a dedicated Opioid Treatment Program (OTP) designed to address opioid use disorder in adults aged 18 and older. Situated conveniently at 61 Industrial Park Road, this facility focuses on providing a comprehensive and individualized approach to recovery. Recognizing addiction as a chronic, treatable disease, the program integrates medical science with behavioral health support to offer patients the best chance at long-term recovery and an improved quality of life.
Integrated Approach to Opioid Treatment
High Point’s Plymouth OTP utilizes Medication-Assisted Treatment (MAT), which is recognized by health experts as the most effective method for treating opioid dependence. This integrated approach combines FDA-approved medications with essential counseling and behavioral therapies. The goal of MAT is to alleviate withdrawal symptoms and curb cravings, helping patients achieve a steady state of mind necessary to engage fully in their therapeutic journey. This dual focus addresses both the biological and psychological aspects of opioid addiction, significantly reducing the risk of relapse.
Core Services Provided
The program is centered on individualized care, ensuring that treatment plans are tailored to meet the unique needs and circumstances of each patient. Key facility services available through the Opioid Treatment Program include:
- Access to crucial Medication-Assisted Treatments for opioid dependence, including daily methadone dosing, Buprenorphine (Suboxone), and Naltrexone (Vivitrol).
- Development of personalized, individualized treatment plans established in collaboration with clinical staff.
- Engagement in therapeutic support through individual counseling sessions.
- Participation in group sessions, fostering peer support and shared recovery experiences.
By offering this full continuum of care, High Point Treatment Center strives to help individuals achieve personal change, accept responsibility for their recovery, and ultimately improve their well-being.
Frequently Asked Questions (FAQs)
Is the Plymouth OTP facility only for opioid addiction?
Yes, the Opioid Treatment Program (OTP) specifically focuses on treating adults aged 18 and older with opioid use disorder, utilizing specialized medication-assisted treatments and counseling services.
What is the difference between methadone and buprenorphine treatment?
Both methadone and buprenorphine are FDA-approved medications used in MAT to reduce cravings and withdrawal symptoms. Methadone is typically administered daily at the facility, while buprenorphine (often combined with naloxone as Suboxone) can sometimes be dispensed for take-home use once a patient meets certain criteria.
How long does treatment in the Opioid Treatment Program last?
Treatment is highly individualized. Medication-Assisted Treatment is a sustained treatment approach, and medications can be taken safely for as long as needed—which can range from months to several years or even indefinitely—depending on the individual’s progress and clinical recommendation.
